YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  


Press Releases

Recipharm increases lyophilisation capacity in Italy

MASATE, ITALY - Aug 26, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced a €3.7 million investment to expand its lyophilisation capacity in Masate, Italy, in response to growing customer demand

Bio-Rad Introduces an Assay Website That Allows Researchers to Identify or Design Their Own Droplet Digital™ PCR Assays

HERCULES, CA, UNITED STATES - Aug 9, 2016 - Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of an assay website that allows droplet digital PCR (ddPCR™) users to locate existing assays or design new ones for mutation detection and copy number determination

Bioclinica Enters Agreement to be Acquired by Cinven

DOYLESTOWN, PA, US - Aug 23, 2016 - Bioclinica®, a provider of specialized technology-enabled services supporting clinical trials, today announced that it has entered a definitive agreement to be acquired by Cinven, a leading international private equity firm

MDI Biological Laboratory Scientists Awarded Patent for Potential New Heart Disease Drug

BAR HARBOR, ME - Aug 23, 2016 - The U.S. Patent and Trademark Office has announced that it will grant a patent to MDI Biological Laboratory scientists Voot P

Is the virtual gene panel the way forward, asks Congenica at Dx Summit

CAMBRIDGE, UNITED KINGDOM - Aug 23, 2016 - Although the current practice of analysing defined gene panels for a specific disease has great utility, it is of limited benefit when a condition is not well defined

PHARMA TECH FIRM EXPANDS US PRESENCE

- Aug 19, 2016 - ZENITH Technologies is expanding its US presence by opening two new offices on the West Coast of the US to meet greater demand for its automation, process control and serialization technology support services

MDI Biological Laboratory Receives Funds for Research on Nerve Damage

BAR HARBOR, ME - Aug 17, 2016 - NIH Grant Will Support Studies on Chemotherapy-Induced Peripheral NeuropathyBAR HARBOR, MAINE -- The MDI Biological Laboratory has announced that it has received a grant of $456,500 over two years from the National Institutes of Health (NIH) for the study of peripheral neuropathy

Mizzou and Danforth Center Leaders to be Featured at the Conversations Program

ST. LOUIS, UNITED STATES - Aug 17, 2016 - The Donald Danforth Plant Science Center’s Conversations Series will be held on Thursday, August 25, 2016, at the Danforth Center, 975 N

Business Consultant Ned Cloonan Joins MDI Biological Laboratory Board

BAR HARBOR, ME - Aug 17, 2016 - BAR HARBOR, MAINE -- The Board of Trustees of the MDI Biological Laboratory has announced the appointment of Ned Cloonan of Greenwich, Conn

NewLeaf Symbiotics Secures Key Patents in Europe and Japan

ST. LOUIS, MO, UNITED STATES - Aug 16, 2016 - NewLeaf Symbiotics announced today that both the European and Japanese Patent Offices will grant patents on the company’s foundational production process

Esteve gains sample management efficiencies using Titian’s Mosaic software

LONDON, UNITED KINGDOM - Aug 15, 2016 - Titian Software (www.titian.co.uk), has announced that deployment of its Mosaic sample management software has resulted in simplified workflows and boosted productivity at Esteve's Compound Management Unit in Barcelona, after replacing their previous system

IDBS provides bespoke software to Cancer Research Technology to streamline plate correction

BOSTON & LONDON - Aug 10, 2016 - IDBS and Cancer Research Technology (CRT), the commercialization arm of Cancer Research UK, have collaborated to streamline plate correction in high throughput screening (HTS)

Certara Releases New Version of its Industry-leading PK/PD Phoenix® Software

PRINCETON, NJ - Aug 10, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of Phoenix 7

BOC Sciences Added the Category of Immune Checkpoint Inhibitors

LONG ISLAND CITY, NY, UNITED STATES - Aug 8, 2016 - BOC Sciences officially announced that a new category of inhibitors-immune checkpoint inhibitors will began to be provided in system

From Sci Fi to Reality: Unlocking the Secret to Growing New Limbs

BAR HARBOR, ME - Aug 5, 2016 - Many lower organisms retain the miraculous ability to regenerate form and function of almost any tissue after injury

Sekisui XenoTech Expands Hepatotoxicity Testing Services

KANSAS CITY, KS, UNITED STATES - Aug 3, 2016 - Sekisui XenoTech has added additional hepatotoxicity screening assays and methodologies to the company’s existing cytotoxicity contract research services

Curable CEO Dr. Lisa Boyette Honored as One of the 100 Most Inspiring People in the Life Sciences industry

PITTSBURGH, PA - Aug 3, 2016 - Curable, a non-profit research accelerator that applies engineering approaches to medicine to develop solutions for rare diseases, today announced that its Chief Executive Officer Lisa Boyette, MD, PhD, has been named a 2016 PharmaVOICE 100 honoree

Definiens Launches Clinical Development Offering to Provide Services from Discovery to Commercialization to Maximize the Success of Drug Programs

MUNICH, GERMANY - Aug 2, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of its Clinical Development Offering, making the company the premier provider of comprehensive tissue-based services from discovery to commercialization

New karyogram display improves Sapientia for clinical diagnosis

CAMBRIDGE, UK - Jul 29, 2016 - As the use of whole genome and exome analysis grows it is increasing the workload for the Genomic Medicine Centres

An Extraordinary Standard: New NIST Protein Could Spur Biopharmaceutical Innovation

GAITHERSBURG, MD - Jul 28, 2016 - The National Institute of Standards and Technology (NIST) has issued one of the world’s most intricate measurement standards: an exhaustively analyzed antibody protein that the biopharmaceutical industry will use to help ensure the quality of treatments across a widening range of health conditions, including cancers, autoimmune disorders and infectious diseases
 1    

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.